;
Author Verified
RCT
Published: Mar 2011
ACE Report #5244
Ace Report Cover Tumour

Denosumab noninferior to zoledronic acid in the treatment of bone metastasis


Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma

J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22

Contributing Authors: J Wang Q Jiang DH Henry L Costa F Goldwasser V Hirsh V Hungria J Prausova GV Scagliotti H Sleeboom A Spencer S Vadhan-Raj R von Moos W Willenbacher PJ Woll S Jun R Dansey H Yeh

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.